Secondary Logo

Share this article on:

It is 2015: what is the best treatment for tinnitus?

Diaz, Rodney C.

Current Opinion in Otolaryngology & Head and Neck Surgery: October 2015 - Volume 23 - Issue 5 - p 360
doi: 10.1097/MOO.0000000000000188
AUDITORY AND VESTIBULAR SCIENCE: Edited by Rodney C. Diaz

Department of Otolaryngology – Head and Neck Surgery, University of California Davis Medical Center, Sacramento, California, USA

Correspondence to Rodney C. Diaz, MD, FACS, Department of Otolaryngology – Head and Neck Surgery, UC Davis Medical Center, 2521 Stockton Boulevard #7200, Sacramento, CA 95817, USA. Tel: +1 916 734 1051; e-mail: rcdiaz@ucdavis.edu

It is 2015: what is the best way to treat tinnitus? And what is your evidence? I am often asked these questions – in various forms and guises – by patients, otolaryngologists, internists, friends, and family members. And while I feel that I am fairly well informed in this field and therefore might be able to offer up a better than average answer intellectually, the simple fact of the matter is that, whatever answers and solutions we have or think we have, it often feels like our treatment options fall short. Tinnitus – chronic subjective tinnitus – is one of the most prevalent ailments in society today, yet, or perhaps because, we lack a cure, or even a prevailing treatment strategy.

In this year's section on ‘Auditory and vestibular science’, we have the great fortune to have invited some of the world's most distinguished clinicians and scientists in the field of tinnitus research – Dr Berthold Langguth (pp. 361–368), Dr Paul van de Heyning (pp. 369–375), Dr Michael Seidman (pp. 376–381), and Professor Fan-Gang Zeng (pp. 382–387) – to help us answer that question, or at least bring us closer.

Back to Top | Article Outline

Acknowledgements

None.

Back to Top | Article Outline

Financial support and sponsorship

None.

Back to Top | Article Outline

Conflicts of interest

Disclosures: The author declares the following: Organization: California Department of Consumer Affairs; Role: Board Member; Description: Speech-Language Pathology, Audiology, and Hearing Aid Dispensers Board. Organization: Auris Medical; Role: Investigator; Description: AM-101 Study – TACTT2. Organization: Auris Medical; Role: Investigator; Description: AM-101 Study – AMPACT1.

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.